C09B21/00

PHENANTHRENE COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES

The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound and a formulation and composition containing one or more of the compounds.

PHENANTHRENE COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES

The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound and a formulation and composition containing one or more of the compounds.

Electrolytic Solution, Electrolytic Aqueous Solution, and Power Generating Device
20190372145 · 2019-12-05 ·

The present invention provides a method for suppressing generation of hydrogen gas at the time when an ion concentration gradient is generated by a temperature responsive electrolyte. An electrolytic solution contains a temperature responsive electrolyte and an oxidation-reduction active species. The temperature responsive electrolyte is an electrolyte whose pKa varies according to the temperature. A power generating device performs power generation by using the electrolytic solution. The power generating device includes a positive electrode, a negative electrode, a heating mechanism, and a cooling mechanism. The positive electrode and the negative electrode are immersed in the electrolytic solution. The heating mechanism heats the electrolytic solution that is present in the vicinity of one of the positive electrode and the negative electrode. The cooling mechanism cools the electrolytic solution that is present in the vicinity of the other one of the positive electrode and the negative electrode.

Azetidine-substituted fluorescent compounds

The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.

Azetidine-substituted fluorescent compounds

The presently-disclosed subject matter includes azetidine-substituted fluorescent compounds, where the compounds may be used as probes, dyes, tags, and the like. The presently-disclosed subject matter also includes kits comprising the same as well as methods for using the same to detect a target substance.

Methods and systems for wireless to power line communication
10483469 · 2019-11-19 · ·

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

Methods and systems for wireless to power line communication
10483469 · 2019-11-19 · ·

Methods, systems, and apparatus for monitoring and controlling electronic devices using wired and wireless protocols are disclosed. The systems and apparatus may monitor their environment for signals from electronic devices. The systems and apparatus may take and disambiguate the signals that are received from the devices in their environment to identify the devices and associate control signals with the devices. The systems and apparatus may use communication means to send control signals to the identified electronic devices. Multiple apparatuses or systems may be connected together into networks, including mesh networks, to make for a more robust architecture.

Passive component for detecting an electrical overload in electrically rotating machines

Various embodiments include a passive component comprising: a substrate; and two conductor tracks disposed on the substrate. The substrate forms an electrically insulating bridge between at least two phases of an electrically rotating machine. Each of the two conductor tracks is coupled to a separate phase of the at least two phases so an electrical potential across the electrically insulating bridge is the same as in the insulation system of the machine and the potential load on the passive component corresponds to the potential load on the insulation system.

Passive component for detecting an electrical overload in electrically rotating machines

Various embodiments include a passive component comprising: a substrate; and two conductor tracks disposed on the substrate. The substrate forms an electrically insulating bridge between at least two phases of an electrically rotating machine. Each of the two conductor tracks is coupled to a separate phase of the at least two phases so an electrical potential across the electrically insulating bridge is the same as in the insulation system of the machine and the potential load on the passive component corresponds to the potential load on the insulation system.

3, 7-diamino-10H-phenothiazine salts and their use

Described are methods of preparing reduced 3,7-diamino-10H-phenothiazine (DAPTZ) compounds of formula: ##STR00001## wherein: R.sup.1 and R.sup.9 are independently selected from: H; C.sub.1-4alkyl; C.sub.2-4alkenyl; and halogenated C.sub.1-4alkyl; each of R.sup.3NA and R.sup.3NB is independently selected from: H; C.sub.1-4alkyl; C.sub.2-4alkenyl; and halogenated C.sub.1-4alkyl; each of R.sup.7NA and R.sup.7NB is independently selected from: H; C.sub.1-4alkyl; C.sub.2-4alkenyl; and halogenated C.sub.1-4alkyl; each of HX.sup.1 and HX.sup.2 is independently a protic acid; and pharmaceutically acceptable salts, solvates, and hydrates thereof. These methods are particularly useful for producing stable reduced forms, and with high purity. The stability and purity are especially relevant for pharmaceutical compositions for the treatment of disease. The compounds are useful for treatment of e.g. tauopathies, such as Alzheimer's disease, and also as prodrugs for the corresponding oxidized thioninium drugs.